MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck

European Journal of Cancer

Volumn 47, Issue 4, 2011, Pages 520-529

  Luangdilok, Sutima ^a   Box, Carol ^a   Harrington, Kevin ^a   Rhŷs Evans, Peter ^b   Eccles, Suzanne ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Epidermal growth factor receptor; Head and neck cancer; Lymphangiogenesis; Mitogen activated protein kinase; Phosphoinositide 3 kinase; Squamous cell carcinoma; Vascular endothelial growth factor A; Vascular endothelial growth factor C

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYTOKINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; VASCULOTROPIN A; VASCULOTROPIN C;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; HEAD AND NECK CARCINOMA; LYMPH VESSEL; LYMPHANGIOGENSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHANGIOGENESIS; MAP KINASE KINASE 1; MAP KINASE KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PATHOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; TOR SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 79851515566     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.10.009     Document Type: Article

References (48)

1. J.L. Lefebvre Current clinical outcomes demand new treatment options for SCCHN Ann Oncol 16 Suppl. 6 2005 vi7 vi12
2. S. Morgan, and J.R. Grandis ErbB receptors in the biology and pathology of the aerodigestive tract Exp Cell Res 315 2009 572 582
3. H.F. Kohler, and L.P. Kowalski How many nodes are needed to stage a neck? A critical appraisal Eur Arch Otorhinolaryngol 267 2010 785 791
4. M.G. Shrime, G. Bachar, and J. Lea Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity Head Neck 31 2009 1482 1488
5. S.J. Rogers, K.J. Harrington, P. Rhys-Evans, P. O-charoenrat, and S.A. Eccles Biological significance of c-erbB family oncogenes in head and neck cancer Cancer Metastasis Rev 24 2005 47 69 (Pubitemid 40576063)
6. P. O-charoenrat, P.H. Rhys-Evans, D.J. Archer, and S.A. Eccles C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors Oral Oncol 38 2002 73 80 (Pubitemid 34076575)
7. K.K. Ang, B.A. Berkey, and X. Tu Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350 7356 (Pubitemid 36025259)
8. M. Lohela, M. Bry, T. Tammela, and K. Alitalo VEGFs and receptors involved in angiogenesis versus lymphangiogenesis Curr Opin Cell Biol 21 2009 154 165
9. M.G. Achen, and S.A. Stacker Molecular control of lymphatic metastasis Ann NY Acad Sci 1131 2008 225 234 (Pubitemid 351758517)
10. S.A. Stacker, and M.G. Achen From anti-angiogenesis to anti-lymphangiogenesis: emerging trends in cancer therapy Lymphat Res Biol 6 2008 165 172
11. Y. Zeng, K. Opeskin, and M.E. Baldwin Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer Clin Cancer Res 10 2004 5137 5144 (Pubitemid 39099788)
12. Z.K. Otrock, J.A. Makarem, and A.I. Shamseddine Vascular endothelial growth factor family of ligands and receptors: review Blood Cells Mol Dis 38 2007 258 268 (Pubitemid 46518176)
13. R. Roskoski Jr. Vascular endothelial growth factor (VEGF) signaling in tumor progression Crit Rev Oncol Hematol 62 2007 179 213 (Pubitemid 46679285)
14. V.M. Leppanen, A.E. Prota, and M. Jeltsch Structural determinants of growth factor binding and specificity by VEGF receptor 2 Proc Natl Acad Sci USA 107 2010 2425 2430
15. A.D. Nash, M. Baca, C. Wright, and P.D. Scotney The biology of vascular endothelial growth factor-B (VEGF-B) Pulm Pharmacol Ther 19 2006 61 69 (Pubitemid 41606854)
16. X. Li, C. Lee, and Z. Tang VEGF-B: a survival, or an angiogenic factor? Cell Adh Migr 3 2009 322 327
17. F. Bahram, and L. Claesson-Welsh VEGF-mediated signal transduction in lymphatic endothelial cells Pathophysiology 17 2010 253 261
18. M. Raica, and D. Ribatti Targeting tumor lymphangiogenesis: an update Curr Med Chem 17 2010 698 708
19. M.L. George, M.G. Tutton, and F. Janssen VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression Neoplasia 3 2001 420 427 (Pubitemid 32988812)
20. P. O-charoenrat, P. Rhys-Evans, and S.A. Eccles Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis Cancer 92 2001 556 568 (Pubitemid 32735191)
21. P.W. Tsai, S.G. Shiah, M.T. Lin, C.W. Wu, and M.L. Kuo Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway J Biol Chem 278 2003 5750 5759
22. P.A. Kyzas, D. Stefanou, A. Batistatou, and N.J. Agnantis Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma J Cancer Res Clin Oncol 131 2005 624 630 (Pubitemid 41558557)
23. Y.K. Hong, B. Lange-Asschenfeldt, and P. Velasco VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins FASEB J 18 2004 1111 1113 (Pubitemid 39561540)
24. C. Scavelli, A. Vacca, G. Di Pietro, F. Dammacco, and D. Ribatti Crosstalk between angiogenesis and lymphangiogenesis in tumor progression Leukemia 18 2004 1054 1058 (Pubitemid 38786962)
25. S. Hirakawa, S. Kodama, and R. Kunstfeld VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis J Exp Med 201 2005 1089 1099 (Pubitemid 40524677)
26. P. O-charoenrat, P. Rhys-Evans, H. Modjtahedi, and S.A. Eccles Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells Clin Exp Metastasis 18 2000 155 161 (Pubitemid 32165249)
27. S. Guillard, P.A. Clarke, and R. Te Poele Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma Cell Cycle 8 2009 443 453
28. F.I. Raynaud, S. Eccles, and P.A. Clarke Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases Cancer Res 67 2007 5840 5850 (Pubitemid 46985018)
29. J. Bain, L. Plater, and M. Elliott The selectivity of protein kinase inhibitors: a further update Biochem J 408 2007 297 315
30. P. O-charoenrat, H. Modjtahedi, and P. Rhys-Evans Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells Cancer Res 60 2000 1121 1128 (Pubitemid 30129555)
31. L. Strauss, D. Volland, M. Kunkel, and T.E. Reichert Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance Med Sci Monit 11 2005 BR280 BR292
32. C.C. Bancroft, Z. Chen, and J. Yeh Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines Int J Cancer 99 2002 538 548 (Pubitemid 34461606)
33. G. Dong, Z. Chen, and Z.Y. Li Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma Cancer Res 61 2001 5911 5918 (Pubitemid 32769111)
34. M.G. Slomiany, L.A. Black, M.M. Kibbey, T.A. Day, and S.A. Rosenzweig IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma Biochem Biophys Res Commun 342 2006 851 858 (Pubitemid 43320476)
35. M. Akagi, M. Kawaguchi, and W. Liu Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells Br J Cancer 88 2003 796 802 (Pubitemid 36411462)
36. S. Xiong, R. Grijalva, and L. Zhang Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration Cancer Res 61 2001 1727 1732 (Pubitemid 34292611)
37. Y. Liu, and B.M. Mueller Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways Biochem Biophys Res Commun 344 2006 1263 1270
38. Y.D. Jung, W. Liu, and N. Reinmuth Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway Angiogenesis 4 2001 155 162 (Pubitemid 34032701)
39. B. Shemirani, and D.L. Crowe Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases Oral Oncol 38 2002 251 257 (Pubitemid 34442546)
40. S. Kobayashi, T. Kishimoto, and S. Kamata Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis Cancer Sci 98 2007 726 733 (Pubitemid 46563450)
41. Y. Tang, D. Zhang, L. Fallavollita, and P. Brodt Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor Cancer Res 63 2003 1166 1171 (Pubitemid 36348689)
42. A. Ristimaki, K. Narko, B. Enholm, V. Joukov, and K. Alitalo Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C J Biol Chem 273 1998 8413 8418 (Pubitemid 28168903)
43. T. Makinen, T. Veikkola, and S. Mustjoki Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 EMBO J 20 2001 4762 4773 (Pubitemid 32848629)
44. D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
45. S.C. Land, and A.R. Tee Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif J Biol Chem 282 2007 20534 20543 (Pubitemid 47100043)
46. S. Tsutsui, A. Matsuyama, and M. Yamamoto The Akt expression correlates with the VEGF-A and -C expression as well as the microvessel and lymphatic vessel density in breast cancer Oncol Rep 23 2010 621 630
47. F. Ciardiello, R. Caputo, and R. Bianco Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor Clin Cancer Res 7 2001 1459 1465 (Pubitemid 32708703)
48. M.X. Da, Z. Wu, and H.W. Tian Tumor lymphangiogenesis and lymphangiogenic growth factors Arch Med Res 39 2008 365 372